Current stock page

Catalysts

AZN Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Oct 21, 2026

AZNAstraZeneca PLC

Healthcare / Drug Manufacturers - General

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$168.45−$0.37 (−0.22%)

Latest quote

  • Momentum
    74
  • Value
    53
  • Quality
    72
  • Risk resilience
    47
  • Sentiment
    67
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 30, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 63/100

Momentum 74/100 and sentiment 67/100 before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 74/100AIQ Edge 9/10 Strong Relative Position
Beat rate
100%
4 of 4 reported periods
Average surprise
+2.9%
Across covered historical reports
Latest result
+5.2%
Jul 27, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 30, 2026—$2.62——$16.06B—
Jul 27, 2026—$2.50$2.63+5.2%$15.44B$15.38B
Apr 29, 2026—$2.57$2.58+0.4%$14.93B$15.29B
Feb 10, 2026—$2.09$2.12+1.4%$15.44B$15.5B
Nov 6, 2025—$2.28$2.38+4.4%$14.78B$15.19B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
10
Buy
1
Hold
1
Sell
12-month analyst target
$216.00
+28.23% versus current price
Based on 1 analyst observations. Targets are estimates, not predictions.
Low target
$216.00
+28.23% vs latest price
Average target
$216.00
+28.23% vs latest price
High target
$216.00
+28.23% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 30, 2026

Next known earnings or reporting date.

EPS estimate$2.59

Current analyst expectation for the upcoming report.

Revenue estimate$16.03B

Current analyst expectation for the upcoming report.

Sentiment score67

News pressure around the setup.

Momentum score74

Where event reaction would show up first.

AIQ score63/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
1
Average target
$216.00
Target upside
28.23%
Target range
$216.00 - $216.00
90-day revisions
-3

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

AZN Catalysts FAQ

What are the next catalysts for AZN stock?

AZN's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move AZN stock?

Upcoming events that could move AZN include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could AZN's next earnings report affect the stock?

AZN's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive AZN stock higher?

AZN could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt AZN stock?

AZN could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.